Sales Outside the U.S. If any currency conversion shall be required in connection with the calculation of payments hereunder, such conversion shall be made using the rate used by Licensee for its financial reporting purposes in accordance with U.S. Generally Accepted Accounting Principles (or foreign equivalent).
Appears in 7 contracts
Samples: License Agreement (Entrada Therapeutics, Inc.), License Agreement (Entrada Therapeutics, Inc.), License Agreement (Entrada Therapeutics, Inc.)
Sales Outside the U.S. If any currency conversion shall be required in connection with the calculation of payments hereunder, such conversion shall be made using the rate used by Licensee for its financial reporting purposes in accordance with U.S. Generally Accepted Accounting Principles (or foreign equivalent)) or, in the absence of such rate, using the average of the buying and selling exchange rate for conversion between the foreign currency and U.S. Dollars, for current transactions as reported in The Wall Street Journal on the last business day of the Contract Quarter to which such payment pertains.
Appears in 5 contracts
Samples: Patent & Technology License Agreement (ADiTx Therapeutics, Inc.), Patent & Technology License Agreement (ADiTx Therapeutics, Inc.), Technology License Agreement
Sales Outside the U.S. If any currency conversion shall be required in connection with the calculation of payments hereunder, such conversion shall be made using the rate used by Licensee for its financial reporting purposes in accordance with U.S. Generally Accepted Accounting Principles (or foreign equivalent).) [***]
Appears in 3 contracts
Samples: Patent and Technology License Agreement (MAIA Biotechnology, Inc.), Patent and Technology License Agreement (MAIA Biotechnology, Inc.), Patent and Technology License Agreement (MAIA Biotechnology, Inc.)
Sales Outside the U.S. If any currency conversion shall be required in connection with the calculation of payments hereunder, such conversion shall be made using the rate used by Licensee for its financial reporting purposes in accordance with U.S. Generally Accepted Accounting Principles (or foreign equivalent).
Appears in 2 contracts
Samples: Technology License Agreement (Cellectis S.A.), Technology License Agreement (Cellectis S.A.)
Sales Outside the U.S. 21818479.1 238213-10001 11 If any currency conversion shall be required in connection with the calculation of payments hereunder, such conversion shall be made using the rate used by Licensee for its financial reporting purposes in accordance with U.S. Generally Accepted Accounting Principles (or foreign equivalent).) [***]
Appears in 1 contract
Samples: Patent and Technology License Agreement (MAIA Biotechnology, Inc.)
